Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Pharmaceutical Holdings Limited (GPHL) is a leading state-owned pharmaceutical enterprise based in Guangzhou, Guangdong, and is one of the largest healthcare companies in China. The company operates across the entire pharmaceutical value chain, including research and development, manufacturing, and distribution of both Traditional Chinese Medicine (TCM) and Western pharmaceuticals. GPHL is well-known for its major subsidiary, Guangzhou Baiyunshan Pharmaceutical Holdings, and iconic brands such as Wong Lo Kat and Chen Liji. Its business portfolio spans chemical drugs, biological products, medical devices, and health services, with a significant focus on innovation in oncology and metabolic diseases. As a dominant player in the South China market, GPHL continues to expand its global footprint through strategic partnerships and a robust pipeline of innovative and generic drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Local Guangdong Pharmacies.